Marketable Securities |
12 Months Ended | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||
Marketable Securities [Abstract] | |||||||||||||||||||||||||||||
Marketable Securities | 3. Marketable Securities The Company acquired equity securities listed in Hong Kong Securities Exchange.
Included in non-operating income (expenses), net unrealized (loss) gain from marketable securities for the years ended March 31, 2023, 2024 and 2025 of $(3,973), $952 and $3,163, respectively. Net proceeds from sale of marketable securities for the years ended March 31, 2023, 2024 and 2025 were $3,854, $ and $5,647, respectively and realized gain from sales of marketable securities for the years ended March 31, 2023, 2024 and 2025 were $581, $ and $1,470, respectively. For the purposes of determining realized gains and losses, the cost of securities sold was determined based on the average cost method.The marketable securities were classified as Level 1 of the hierarchy established under ASC No. 820 because the valuations were based on quoted prices for identical securities in active markets. |